Jones Financial Companies
INDV icon

Jones Financial Companies’s Indivior Pharmaceuticals INDV Stock Holding History

Jones Financial Companies’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.9K Buy
1,982
+1,344
+211% +$48.8K ﹤0.01% 2920
2026
Q1 		$18.5K Buy
638
+282
+79% +$9.31K ﹤0.01% 3330
2025
Q4 		$12.8K Buy
356
+291
+448% +$8.88K ﹤0.01% 3117
2025
Q3 		$1.55K Buy
+65
New +$1.36K ﹤0.01% 3768

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's INDV Position: Q2 2026 in Review

Jones Financial Companies increased its Indivior Pharmaceuticals (INDV) stake by 211% in Q2 2026, buying an estimated $48.8K and bringing the position to 1,982 shares worth $82.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

Jones Financial Companies first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Jones Financial Companies held 1,982 shares of Indivior Pharmaceuticals worth $82.9K as of Q2 2026.
  • Jones Financial Companies bought 1,344 Indivior Pharmaceuticals shares in Q2 2026, an estimated $48.8K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2920 holding.
  • Jones Financial Companies first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.